Revenue and earnings declined sharply in H1 2025/26 due to an unfavorable product mix and reduced orders, with management expecting results at the lower end of guidance. Cost reductions and a strong liquidity position support long-term growth ambitions.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.